Christopher McGuinness
Direktor/Vorstandsmitglied bei Watchmaker Genomics, Inc.
Profil
Chris currently serves as the Chief Operating Office of Kapa Biosystems.
He spent much of his career as a project manager and entrepreneur in the telecommunications field.
Chris was a founder of ECHO, a broadband network engineering firm, which was purchased by Keppel Communications in 2003.
Chris holds a BS in Physics from Emory University and an MBA, with a focus in finance, from The University of Chicago School of Business.
Chris is an investment committee member of Table Mountain Capital, LLC and managing member of McGuinness Investments LLC.
Aktive Positionen von Christopher McGuinness
| Unternehmen | Position | Beginn |
|---|---|---|
Table Mountain Capital LLC
 Table Mountain Capital LLC Investment ManagersFinance Table Mountain Capital LLC (Table Mountain Capital) is a venture capital firm founded in 2006. The firm is headquartered in Boulder, Colorado. | Private Equity Investor | - |
Watchmaker Genomics, Inc.
 Watchmaker Genomics, Inc. BiotechnologyHealth Technology Watchmaker Genomics, Inc. applies advanced enzymology to enable breakthrough applications for the reading, writing, and editing of DNA and RNA. Based in Boulder, CO, the Watchmaker team brings decades of collective experience building successful life science companies, commercializing novel technologies, and advancing clinical genomics applications. The company's product portfolio includes enzymes and kits for next-generation sequencing library preparation, synthetic biology, and molecular diagnostics. Watchmaker partners directly with innovative life science companies, commercial sequencing providers, and pioneering research labs. The CEO of the company is John F. Foskett. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Christopher McGuinness
| Unternehmen | Position | Ende |
|---|---|---|
Kapa Biosystems, Inc.
 Kapa Biosystems, Inc. BiotechnologyHealth Technology Kapa Biosystems, Inc. provides genomic tools. It develops solutions that accelerate genomics research to diagnose, monitor, and treat cancer and complex inherited and infectious diseases. The company was founded by John Foskett, Paul McEwan, Ron McEwan, and Christopher McGuinness in 2006 and is headquartered in Wilmington, MA. | Gründer | 01.09.2016 |
| Echo Networks | Gründer | 31.12.2002 |
Ausbildung von Christopher McGuinness
| Emory University | Undergraduate Degree |
| The University of Chicago | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Table Mountain Capital LLC
Table Mountain Capital LLC Investment ManagersFinance Table Mountain Capital LLC (Table Mountain Capital) is a venture capital firm founded in 2006. The firm is headquartered in Boulder, Colorado. | Finance |
| Echo Networks | |
Kapa Biosystems, Inc.
Kapa Biosystems, Inc. BiotechnologyHealth Technology Kapa Biosystems, Inc. provides genomic tools. It develops solutions that accelerate genomics research to diagnose, monitor, and treat cancer and complex inherited and infectious diseases. The company was founded by John Foskett, Paul McEwan, Ron McEwan, and Christopher McGuinness in 2006 and is headquartered in Wilmington, MA. | Health Technology |
Watchmaker Genomics, Inc.
Watchmaker Genomics, Inc. BiotechnologyHealth Technology Watchmaker Genomics, Inc. applies advanced enzymology to enable breakthrough applications for the reading, writing, and editing of DNA and RNA. Based in Boulder, CO, the Watchmaker team brings decades of collective experience building successful life science companies, commercializing novel technologies, and advancing clinical genomics applications. The company's product portfolio includes enzymes and kits for next-generation sequencing library preparation, synthetic biology, and molecular diagnostics. Watchmaker partners directly with innovative life science companies, commercial sequencing providers, and pioneering research labs. The CEO of the company is John F. Foskett. | Health Technology |
